Celltrion: Arthritis, Rheumatoid trials

The registry lists 13 Arthritis, Rheumatoid studies with Celltrion as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 2Phase 3 9No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid ArthritisCompletedNCT05489224Phase 3Results posted
• A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid ArthritisCompletedNCT04171414Phase 3Results posted
• A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid ArthritisCompletedNCT03789292Phase 3Results posted
• A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RACompletedNCT03147248Phase 3Results posted
• An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RATerminatedNCT02557295Results posted
• PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid ArthritisCompletedNCT02149121Phase 3Results posted
• A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and PsActive, not recruitingNCT05866614
• A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid ArthritisStatus unknownNCT05725434Phase 3
• To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT03707535Phase 3
• Long-Term Efficacy and Safety of CT-P10 in Patients With RACompletedNCT01873443Phase 1
• An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1CompletedNCT01571219Phase 3
• Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid ArthritisCompletedNCT01534884Phase 1
• Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)CompletedNCT01217086Phase 3